The Technical Analyst
Select Language :
Artelo Biosciences Inc [ARTL]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Artelo Biosciences Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Artelo Biosciences Inc is listed at the  Exchange

-0.67% $1.480

America/New_York / 28 mar 2024 @ 16:00


Artelo Biosciences Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 4.78 mill
EPS: -3.33
P/E: -0.440
Earnings Date: May 09, 2024
SharesOutstanding: 3.23 mill
Avg Daily Volume: 0.0179 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.440 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.07x
Company: PE -0.440 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$2.41
(62.78%) $0.929
Date: 2024-03-29
Expected Trading Range (DAY)

$ 1.385 - 1.575

( +/- 6.42%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-28 Favorito Tamara A Buy 2 000 Stock Option (right to buy)
2024-02-28 Favorito Tamara A Buy 1 083 Stock Option (right to buy)
2024-02-28 Favorito Tamara A Buy 667 Stock Option (right to buy)
2024-02-28 Favorito Tamara A Sell 1 083 Stock Option (right to buy)
2024-02-28 Favorito Tamara A Sell 2 000 Stock Option (right to buy)
INSIDER POWER
16.62
Last 100 transactions
Buy: 2 033 762 | Sell: 346 866

Forecast: 16:00 - $1.480

Live Trading Signals (every 1 min)

Forecast 1: 14:55 - $1.492
Forecast 2: 15:45 - $1.496
Forecast 3: 16:00 - $1.480
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $1.480 (-0.67% )
Volume 0.0160 mill
Avg. Vol. 0.0179 mill
% of Avg. Vol 89.31 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Artelo Biosciences Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Artelo Biosciences Inc

RSI

Last 10 Buy & Sell Signals For ARTL

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Artelo Biosciences Inc

ARTL

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Last 10 Buy Signals

Date Signal @
UNCXUSDMar 29 - 03:44328.38
TRIASUSDMar 29 - 03:4412.46
NANOUSDMar 29 - 03:45$1.656
OGUSDMar 29 - 03:445.86
HAPIUSDMar 29 - 03:4523.08
FRONTUSDMar 29 - 03:44$1.250
JUVUSDMar 29 - 03:442.91
ETHUPUSDMar 29 - 03:4434.29
MEDIAUSDMar 29 - 03:4421.49
ARBUSDMar 29 - 03:441.630

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.